(Q36703598)

15 August 2017

1 reference

title

Pharmacogenomics and nutrigenomics: synergies and differences (English)

1 reference

15 August 2017

1 reference

Ghosh D

1

1 reference

15 August 2017

Skinner MA

series ordinal

2

1 reference

15 August 2017

Laing WA

series ordinal

3

1 reference

15 August 2017

publication date

10 January 2007

1 reference

European Journal of Clinical Nutrition

15 August 2017

published in

1 reference

15 August 2017

volume

61

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

567-574

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1602590

15 August 2017

exact match

0 references

cites work

Deconstructing the relationship between genetics and race

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Angiotensin I-converting enzyme gene polymorphism and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Bioethics in human nutrigenomics research: European Nutrigenomics Organisation workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

HMG-CoA reductase inhibitors induce COX-2 gene expression in murine macrophages: role of MAPK cascades and promoter elements for CREB and C/EBPbeta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Drug discovery from natural sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutrigenomics: the impact of biomics technology on nutrition research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

National surveillance of emergency department visits for outpatient adverse drug events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutritional genomics: manipulating plant micronutrients to improve human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Readmissions and adverse drug reactions in internal medicine: the economic impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Medicine. Race and reification in science

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Pharmacogenomics and individualized drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Moving towards individualized medicine with pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Cancer epigenetics takes center stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutrigenomics: integrating genomic approaches into nutrition research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Structural variation in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

The structure of haplotype blocks in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Emerging concepts in nutrigenomics: a preview of what is to come

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutrigenomics: the Rubicon of molecular nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Inflammatory status and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Pharmacogenomics and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Genomic medicine--a primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Welcome to the genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

The case for strategic international alliances to harness nutritional genomics for public and personal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutritional genomics: the next frontier in the postgenomic era

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutrigenomics: unraveling man's constitution in relation to food

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Sequencing drug response with HapMap

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

What is the bottom line for dietary guidelines when taking monoamine oxidase inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Science, medicine, and the future: Postgenomic technologies: hunting the genes for common disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

The effects of niacin on lipoprotein subclass distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Fetal Malformations and Folate Metabolism: Review of Recent Evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutrigenomics: goals and strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutrigenomics and nutrigenetics: the emerging faces of nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutrigenetics, plasma lipids, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutrigenomics and nutrigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Conclusion: genetic diversity and science communication - some issues of 'translation' and language.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

21 January 2018

Food-drug interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Pharmacogenomics of cholesterol-lowering therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Pharmacogenetics and the concept of individualized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

21 January 2018

Big Pharma's Commedia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Role of genetic factors in the pathogenesis of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Update in retinoid therapy of acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Nutrigenomics: exploiting systems biology in the nutrition and health arenas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

. . .to a future of genetic medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

Genetic variation and nutrition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

Hypotensive peptides from milk proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

Influence of zinc, D-penicillamine and oxygen on poisoning with Amanita phalloides. Zinc accelerates liver regeneration and prevents the depletion of brain noradrenaline caused by the mushroom

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

Genomics and metabolomics as markers for the interaction of diet and health: lessons from lipids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

Influence of human genetic variation on nutritional requirements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

Nutritional genomics - "Nutrigenomics"

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

Early Detection and Risk Assessment Proceedings and Recommendations from the Workshop on Epigenetics in Cancer Prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

2001 W.O. Atwater Memorial Lecture and the 2001 ASNS President's Lecture: Human nutrient requirements: the challenge of the post-genome era.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602590

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1602590

1 reference

15 August 2017

1 reference